We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
COVERAM LD Servier Laboratories (Aust) Pty Ltd
Product name
COVERAM LD
Accepted date
Jun-2025
Active ingredients
amlodipine besilate, perindopril arginine
Proposed indication
COVERAM is for the treatment of high blood pressure and/or stable coronary heart disease in patients already taking perindopril and amlodipine.
Application type
C (new indication)
Publication date
Jun-2025